What is potential (it's not a potential because researchers are already using it) for PACB? Look at facts before traders and large investors come stamping.
- Longer reads and finished genome. Researchers are already using it as you can see from published research at PubMed. This is good for science and excellent for PACB.
-Every quarter PACB is doubling run yield and read length which is very positive.
-PACB is selling more sequencers that is very positive sign.
-In 2013 ( which start in April, 2013 for grants and projects ), more and more projects will be using PACB because that's the best sequencing can offer.